Search Results - "Alexander, Marcus"
-
1
Navigating the new landscape of second‐line treatment in advanced hepatocellular carcinoma
Published in Liver international (01-08-2020)“…Sorafenib and lenvatinib are approved for first‐line treatment of patients with advanced hepatocellular carcinoma (HCC), and the efficacy of atezolizumab plus…”
Get full text
Journal Article -
2
HCC therapies—lessons learned
Published in Nature reviews. Gastroenterology & hepatology (01-07-2014)“…Advancing the field of therapeutics for hepatocellular carcinoma has been far more challenging than initially anticipated; sorafenib is the only approved…”
Get full text
Journal Article -
3
Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany
Published in Alimentary pharmacology & therapeutics (01-11-2018)“…Summary Background Advanced fibrosis has been established as the most important predictor of overall mortality in patients with non‐alcoholic fatty liver…”
Get full text
Journal Article -
4
Quantitative Particle Uptake by Cells as Analyzed by Different Methods
Published in Angewandte Chemie International Edition (27-03-2020)“…There is a large number of two‐dimensional static in vitro studies about the uptake of colloidal nano‐ and microparticles, which has been published in the last…”
Get full text
Journal Article -
5
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
Published in American journal of transplantation (01-11-2019)“…Regorafenib is one option for second‐line treatment of hepatocellular carcinoma (HCC), improving overall survival (OS) of sorafenib‐tolerant patients who…”
Get full text
Journal Article -
6
Hydrogels as Emerging Materials for Cornea Wound Healing
Published in Small (Weinheim an der Bergstrasse, Germany) (01-07-2021)“…Hydrogel biomaterials have many favorable characteristics including tuneable mechanical behavior, cytocompatibility, optical properties suitable for…”
Get full text
Journal Article -
7
Letter: diabetes mellitus increases the risk of hepatic encephalopathy in patients with cirrhosis—authors’ reply
Published in Alimentary pharmacology & therapeutics (01-10-2020)“…LINKED CONTENT This article is linked to Labenz et al and Liu et al papers. To view these articles, visit https://doi.org/10.1111/apt.15915 and…”
Get full text
Journal Article -
8
Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy
Published in Alimentary pharmacology & therapeutics (01-11-2019)“…Summary Background Systemic inflammation is a driving force for the development of hepatic encephalopathy and recent studies demonstrated that elevated…”
Get full text
Journal Article -
9
How COVID-19 kick-started online learning in medical education-The DigiMed study
Published in PloS one (21-09-2021)“…The coronavirus disease 2019 (COVID-19) pandemic led to far-reaching restrictions of social and professional life, affecting societies all over the world. To…”
Get full text
Journal Article -
10
Natural polymers in wound healing: From academic studies to commercial products
Published in Journal of applied polymer science (10-06-2023)“…Natural biopolymers (carbohydrates and proteins) are the family of natural polymers that are widely used in wound healing. This is due to their…”
Get full text
Journal Article -
11
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population‐based study
Published in Alimentary pharmacology & therapeutics (01-09-2020)“…Summary Background Bone fractures are a frequent complication in patients with cirrhosis. Proton pump inhibitors (PPIs) are among the most frequently…”
Get full text
Journal Article -
12
Context Modularity of Human Altruism
Published in Science (American Association for the Advancement of Science) (09-12-2011)“…Whereas altruism drives the evolution of human cooperation, ethno-religious diversity has been considered to obstruct it, leading to poverty, corruption, and…”
Get full text
Journal Article -
13
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection
Published in Liver international (01-05-2020)“…Background and Aims Chronic hepatitis C virus (HCV) infection increases the risk of incident chronic kidney disease (CKD) and progression to end‐stage renal…”
Get full text
Journal Article -
14
Immune oncology in hepatocellular carcinoma—hype and hope
Published in The Lancet (British edition) (24-06-2017)“…Thus, the definition of a first and so far only standard of care for hepatocellular carcinoma, a milestone 10 years ago, was followed by gridlock; no standard…”
Get full text
Journal Article -
15
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis
Published in Alimentary pharmacology & therapeutics (01-08-2020)“…Summary Background Diabetes mellitus may lead to increased serum ammonia and systemic inflammation thereby promoting hepatic encephalopathy (HE). Aim To…”
Get full text
Journal Article -
16
Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL
Published in Journal of hepatology (01-09-2022)“…Detection of patients with early cirrhosis is of importance to prevent the occurrence of complications and improve prognosis. The SEAL program aimed at…”
Get full text
Journal Article -
17
Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
Published in Scientific reports (15-10-2021)“…Methylglyoxal (MGO) is a highly reactive dicarbonyl species that forms advanced glycation end products (AGEs). The binding of these AGEs to their receptor…”
Get full text
Journal Article -
18
Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
Published in Medicine (Baltimore) (11-12-2020)“…There is evidence that intake of proton pump inhibitors (PPI) increases the risk for spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis…”
Get full text
Journal Article -
19
Transient binding of dynein controls bidirectional long-range motility of early endosomes
Published in Proceedings of the National Academy of Sciences - PNAS (01-03-2011)“…In many cell types, bidirectional long-range endosome transport is mediated by the opposing motor proteins dynein and kinesin-3. Here we use a fungal model…”
Get full text
Journal Article -
20
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
Published in Journal of investigative medicine (01-08-2020)“…Predictive factors for adverse outcomes in patients with COVID-19 are urgently needed. Data related to the applicability of the Clinical Frailty Scale (CFS)…”
Get full text
Journal Article